Moderna founder launches Apriori with $50M to stay ahead of virus variants
Bio Pharma Dive
JULY 11, 2022
Flagship Pioneering’s latest startup aims to use predictive technology to find “variant-proof” treatments and vaccines for infectious diseases before they might be needed.
Let's personalize your content